TRISHA SEMBHI: Open Payments
NPI 1265838932 · BETHLEHEM, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,822 in 80 payments from 15 companies in 2025. Trend: 2023 $1,596 · 2024 $446 · 2025 $1,822
Food & beverage: $1,673Education: $149
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 12 | $435 |
| UCB, Inc. | 10 | $226 |
| GENZYME CORPORATION | 8 | $189 |
| LEO Pharma Inc. | 10 | $153 |
| ABBVIE INC. | 10 | $142 |
| Janssen Biotech, Inc. | 6 | $140 |
| Novartis Pharmaceuticals Corporation | 5 | $119 |
| Regeneron Healthcare Solutions, Inc. | 2 | $99 |
| Organon LLC | 6 | $89 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $76 |
Products named: NEMLUVIO, DUPIXENT, Bimzelx, TREMFYA, SKYRIZI, ANZUPGO, COSENTYX, OTEZLA.
Industry payments across PA — which companies pay providers there.
